换一批Calcineurin inhibitor-free graft-versus-host disease prophylaxis with sirolimus and mycophenolate mofetil in a second allogeneic stem cell transplantation for engraftment failure and rituximab-refractory Epstein-Barr virus-induced posttransplant lymphoproliferative disease.
第一作者：
Francesco,Ceppi
第一单位：
*Department of Pediatrics, Division of Hematology-Oncology, Centre de Cancérologie Charles-Bruneau †Department of Pharmacy ‡Department of Pediatrics, Division of Infectious Disease §Department of Microbiology, Laboratory of Molecular Virology and Serology, University of Montreal, Sainte Justine Hospital, Montreal, Canada.
作者：
医学主题词
抗体, 单克隆, 鼠源性(Antibodies, Monoclonal, Murine-Derived);抗肿瘤药(Antineoplastic Agents);钙神经素(Calcineurin);儿童(Child);综合疗法(Combined Modality Therapy);抗药性, 肿瘤(Drug Resistance, Neoplasm);移植物抗宿主病(Graft vs Host Disease);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);免疫抑制剂(Immunosuppressive Agents);淋巴组织增殖性疾病(Lymphoproliferative Disorders);男(雄)性(Male);霉酚酸(Mycophenolic Acid);前体T细胞淋巴母细胞白血病淋巴瘤(Precursor T-Cell Lymphoblastic Leukemia-Lymphoma);预后(Prognosis);西罗莫司(Sirolimus);移植预处理(Transplantation Conditioning);移植, 同种(Transplantation, Homologous);阿糖腺苷(Vidarabine)
DOI
10.1097/MPH.0000000000000066
PMID
24977404
发布时间
2016-11-25
- 浏览17
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
